In this burgeoning era of personalized medicine we have witnessed a humongous increase
in novel therapeutics encompassing wide range of modalities including small molecule …

Drug delivery systems largely contribute to cancer therapy in terms of tumor targeting and
controlled release of cargo molecules. While targeting of tumor “tissue” has been achieved …

Recent developments in molecular biology and cell biology have led to the discovery of
novel genes and proteins having therapeutic potentials for various diseases including …

Gene therapy is a process designed to introduce a genetic material into the cell to make a
beneficial protein either by silencing the abnormal or mutated gene, by introducing a copy of …

Nanomedicine applied to drug delivery can be broadly defined as" approaches,
formulations, technologies, and systems for transporting a pharmaceutical compound in the …

Background: Nanocarriers have been a part of drug delivery for some decades now. Due to
the enormous advantages offered by them, they are replacing the conventionally available …

Cancer is a disease characterized by the uncontrolled growth of cells and is the leading
cause of death worldwide with an incidence of 11 million new cases each year …

Many types of nanocarriers are currently being used to deliver various types of anticancer
agents including drugs, proteins/peptides, oligonucleotides, siRNA, and DNA. These …

Nanocarriers offer unique possibilities to overcome cellular barriers in order to improve the
delivery of various drugs and drug candidates, including the promising therapeutic …

With its rapid development in the past few decades, gene therapy has shown potential for
use as a standard clinical intervention for the treatment of several conditions, including …